Additionally, HEX loaded with an antisense oligonucleotide (ASO) targeting STAT6 selectively silenced expression of this transcription factor in colorectal cancer and HCC mouse models; combined with anti-PD1 immunotherapy, this led to greater than 90% inhibition of tumor growth (74) (Table 3). The gene discussed is STAT6; the disease is hepatocellular carcinoma.